XT
FTH

XTX Topco’s Faeth Therapeutics FTH Stock Holding History

XTX Topco’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
+9,608
New +$222K ﹤0.01% 3101
2025
Q1 		– Sell
-3,145
Closed -$30.8K – 3053
2024
Q4 		$30.8K Buy
3,145
+2,449
+352% +$24.6K ﹤0.01% 1974
2024
Q3 		$8.33K Sell
696
-6
-0.9% -$73 ﹤0.01% 1943
2024
Q2 		$8.71K Buy
+702
New +$14.6K ﹤0.01% 1703

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

XTX Topco's FTH Position: Q2 2026 in Review

XTX Topco opened a new position in Faeth Therapeutics (FTH) in Q2 2026: 9,608 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #3101 among its holdings. This is a return to the name: XTX Topco previously reported a position in FTH as recently as Q4 2024.

XTX Topco first reported a position in FTH in Q2 2024 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • XTX Topco held 9,608 shares of Faeth Therapeutics worth $240K as of Q2 2026.
  • Faeth Therapeutics was a new XTX Topco position in Q2 2026.
  • Faeth Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3101 holding.
  • XTX Topco first reported a position in Faeth Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.